REFERENCES
- Lipman AG. Opioid overdose deaths: reactions and overreactions. J Pain Palliat Care Pharmacother. 2012;26:3–4.
- Bakalar N. Title. New York Times. 2012;12. Available at: http: // www.nytimes.com/2011/12/27/health/more-americans-died-of-poisoning-than-in-car-crashes-in-2008.html. Accessed March 22, 2012.
- Feldman L, Williams KS, Coates J, Knox M. Awareness and utilization of a prescription monitoring program among physicians. J Pain Palliat Care Pharmacother. 2011;25:313–317.
- Krakauer EL, Wenk R, Buitrago R, Jenkins P, Scholten W. Opioid inaccessibility and its human consequences: reports from the field. J Pain Palliat Care Pharmacother. 2010;24:239–243.
- Craig DS. The Food and Drug Administration risk evaluation and mitigation strategy. J Pain Palliat Care Pharmacother. 2010;24:145–148.
- Gudin J. Risk Evaluation and Mitigation Strategies (REMS) for extended-release and long-acting opioid analgesics: considerations for pain and palliative care practice. J Pain Palliat Care Pharmacother. 2012;26:136–143.
- Craig DS. Are opioid REMS interrupting your sleep? J Pain Palliat Care Pharmacother. 2012;26:134–135.
- Food and Drug Administration. Shared risk evaluation mitigation strategy for all immediate release transmucosal fentanyl dosage forms. J Pain Palliat Care Pharmacother. 2012;26:xx–xx.
- Center for Drug Evaluation and Research. Blueprint for Prescriber Continuing Education Program. J Pain Palliat Care Pharmacother. 2012;26:xx–xx.